K-RAS STATUS DOES NOT PREDICT SUCCESSFUL HEPATIC RESECTION OF COLORECTAL-CANCER METASTASIS

被引:0
|
作者
KASTRINAKIS, WV [1 ]
RAMCHURREN, N [1 ]
MAGGARD, M [1 ]
STEELE, G [1 ]
SUMMERHAYES, IC [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To establish whether specific K-ras alterations are predictive of less aggressive turner behavior and subsequently those patients who are most likely to benefit from resection of hepatic metastases from colorectal carcinoma. Design: Evaluation of long-term survivors of hepatic resection for metastases of colorectal carcinoma (median survival, 85 months). Results: DNA, extracted from 26 paraffin-embedded hepatic metastases from 19 patients, was analyzed using single-strand conformation polymorphism and direct sequence analysis of codons 12 and 13 of the K-ras gene. Seven of 19 patients were found to harbor K-uas mutations. A similar frequency and spectrum of K-uas mutational events was detected in 14 patients with shortterm survival following pathologic diagnosis of hepatic metastasis. Conclusions: Neither the presence of a K-vas mutational event nor the precise nucleotide change are predictive of less aggressive tumor behavior, and genetic alterations at this locus alone cannot be used to select patients undergoing resection of hepatic metastases from colorectal carcinoma.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [21] ALTERATIONS OF P53 AND K-RAS GENES IN HUMAN COLORECTAL-CANCER WITH ULCERATIVE-COLITIS
    TSURUTA, H
    URANO, T
    MAKIYAMA, K
    ABE, K
    ITSUNO, M
    HARA, K
    SHIKU, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (04) : 767 - 772
  • [22] IS SURGICAL INTERVENTION NECESSARY FOR HEPATIC METASTASIS OF COLORECTAL-CANCER
    ARNAUD, JP
    PARIS, F
    THEBAULT, Y
    SCHLOEGEL, M
    SCHAAL, JC
    MASSARD, G
    JAECK, D
    ADLOFF, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1989, 13 (2BIS): : A123 - A123
  • [23] RESECTION OF HEPATIC AND PULMONARY METASTASES IN PATIENTS WITH COLORECTAL-CANCER
    GOUGH, DB
    DONOHUE, JH
    TRASTEK, VA
    NAGORNEY, DM
    BRITISH JOURNAL OF SURGERY, 1994, 81 (01) : 94 - 96
  • [24] AGGRESSIVE HEPATIC RESECTION FOR METASTASES FROM COLORECTAL-CANCER
    OKAMOTO, S
    TAKAYASU, T
    SHIMABUKURO, T
    UEDA, M
    NAGAMATSU, K
    YAMAMOTO, Y
    YAMAOKA, Y
    GASTROENTEROLOGY, 1994, 106 (04) : A954 - A954
  • [25] K-ras mutation in colorectal cancer treated with cetuximab
    Barbareschi, M.
    Girlando, S.
    Soini, B.
    Cuorvo, L.
    Fasanella, S.
    Cantaloni, C.
    Piccolo, A.
    Prosdocimi, F.
    Galligioni, E.
    Dalla Palma, P.
    VIRCHOWS ARCHIV, 2009, 455 : 396 - 396
  • [26] K-RAS gene mutations and susceptibility to colorectal cancer
    Prasad, S. S.
    Sekaran, A.
    Rao, G. V.
    Rebala, P.
    Tandan, M.
    Kaitha, A.
    Reddy, D. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 221 - 222
  • [27] K-ras Mutations in the Plasma of Colorectal Cancer Patients
    Shen, Yong-qi
    Ye, Yun-bin
    Zheng, Xiong-wei
    Li, Chao
    Chen, Qiang
    LABMEDICINE, 2010, 41 (03): : 156 - 158
  • [28] Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer
    Milano, G.
    Etienne-Grimaldi, M. -C.
    Dahan, L.
    Francoual, M.
    Spano, J. -P.
    Benchimol, D.
    Chazal, M.
    Letoublon, C.
    Andre, T.
    Gilly, F. -N.
    Delpero, J. -R.
    Formento, J. -L.
    ANNALS OF ONCOLOGY, 2008, 19 (12) : 2033 - 2038
  • [29] Therapeutic modulation of k-ras signaling in colorectal cancer
    Krens, Lisanne L.
    Baas, Jara M.
    Gelderblom, Hans
    Guchelaar, Henk-Jan
    DRUG DISCOVERY TODAY, 2010, 15 (13-14) : 502 - 516
  • [30] K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients
    Zhu, D
    Keohavong, P
    Finkelstein, SD
    Swalsky, P
    Bakker, A
    Weissfeld, J
    Srivastava, S
    Whiteside, TL
    CANCER RESEARCH, 1997, 57 (12) : 2485 - 2492